Correlation Between NeuPath Health and Extendicare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NeuPath Health and Extendicare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeuPath Health and Extendicare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NeuPath Health and Extendicare, you can compare the effects of market volatilities on NeuPath Health and Extendicare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeuPath Health with a short position of Extendicare. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeuPath Health and Extendicare.

Diversification Opportunities for NeuPath Health and Extendicare

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between NeuPath and Extendicare is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding NeuPath Health and Extendicare in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Extendicare and NeuPath Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeuPath Health are associated (or correlated) with Extendicare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Extendicare has no effect on the direction of NeuPath Health i.e., NeuPath Health and Extendicare go up and down completely randomly.

Pair Corralation between NeuPath Health and Extendicare

Assuming the 90 days trading horizon NeuPath Health is expected to generate 2.2 times less return on investment than Extendicare. In addition to that, NeuPath Health is 2.64 times more volatile than Extendicare. It trades about 0.02 of its total potential returns per unit of risk. Extendicare is currently generating about 0.11 per unit of volatility. If you would invest  684.00  in Extendicare on September 14, 2024 and sell it today you would earn a total of  340.00  from holding Extendicare or generate 49.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

NeuPath Health  vs.  Extendicare

 Performance 
       Timeline  
NeuPath Health 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in NeuPath Health are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, NeuPath Health is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Extendicare 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Extendicare are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, Extendicare may actually be approaching a critical reversion point that can send shares even higher in January 2025.

NeuPath Health and Extendicare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NeuPath Health and Extendicare

The main advantage of trading using opposite NeuPath Health and Extendicare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeuPath Health position performs unexpectedly, Extendicare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Extendicare will offset losses from the drop in Extendicare's long position.
The idea behind NeuPath Health and Extendicare pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum